Follow Us
© 2026 Arizent. All rights reserved.
Stefan Canizares is an associate with Foley & Larder LLP. He is a member of the Business Litigation & Dispute Resolution Practice.
For reprint and licensing requests for this article, click here.
Despite not being a mandate, the passing of the bill could make a big difference in leaders’ approach.
As healthcare expenses approach double-digit increases, employers are looking for savings in waste, care delivery, and plan administration before cutting benefits.
While the legislation's future is still unclear, there are many important things for leaders to know.
A financial spreadsheet alone cannot capture the total value and performance of a benefits program, nor can numbers on a ledger guarantee long-term operational success.
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
